1. Home
  2. ASNS vs ENSC Comparison

ASNS vs ENSC Comparison

Compare ASNS & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASNS
  • ENSC
  • Stock Information
  • Founded
  • ASNS 1998
  • ENSC 2003
  • Country
  • ASNS United States
  • ENSC United States
  • Employees
  • ASNS N/A
  • ENSC N/A
  • Industry
  • ASNS Telecommunications Equipment
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASNS Telecommunications
  • ENSC Health Care
  • Exchange
  • ASNS Nasdaq
  • ENSC Nasdaq
  • Market Cap
  • ASNS 6.7M
  • ENSC 6.4M
  • IPO Year
  • ASNS 2022
  • ENSC N/A
  • Fundamental
  • Price
  • ASNS $0.43
  • ENSC $2.10
  • Analyst Decision
  • ASNS Strong Buy
  • ENSC
  • Analyst Count
  • ASNS 1
  • ENSC 0
  • Target Price
  • ASNS $5.00
  • ENSC N/A
  • AVG Volume (30 Days)
  • ASNS 9.0M
  • ENSC 56.3K
  • Earning Date
  • ASNS 11-13-2025
  • ENSC 11-11-2025
  • Dividend Yield
  • ASNS N/A
  • ENSC N/A
  • EPS Growth
  • ASNS N/A
  • ENSC N/A
  • EPS
  • ASNS N/A
  • ENSC N/A
  • Revenue
  • ASNS $5,265,000.00
  • ENSC $7,413,722.00
  • Revenue This Year
  • ASNS N/A
  • ENSC N/A
  • Revenue Next Year
  • ASNS $104.77
  • ENSC $1,354.55
  • P/E Ratio
  • ASNS N/A
  • ENSC N/A
  • Revenue Growth
  • ASNS N/A
  • ENSC 415.58
  • 52 Week Low
  • ASNS $0.34
  • ENSC $1.62
  • 52 Week High
  • ASNS $1.78
  • ENSC $14.67
  • Technical
  • Relative Strength Index (RSI)
  • ASNS 44.26
  • ENSC 48.61
  • Support Level
  • ASNS $0.42
  • ENSC $2.02
  • Resistance Level
  • ASNS $0.52
  • ENSC $2.19
  • Average True Range (ATR)
  • ASNS 0.07
  • ENSC 0.10
  • MACD
  • ASNS 0.01
  • ENSC 0.00
  • Stochastic Oscillator
  • ASNS 31.25
  • ENSC 41.45

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: